Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη τύπου ασθενών-μαρτύρων σε άνδρες με χρόνια νεφρική νόσο για τη διερεύνηση της φυσικής ιστορίας της στυτικής δυσλειτουργίας σε σχέση με την επίδραση της αιμοκάθαρσης σε πληθυσμό ανδρών ασθενών με χρόνια νεφρική νόσο

Abstract

dc:description

This dissertation investigated, within a prospective longitudinal framework, the burden of sexual dysfunction in men with chronic kidney disease and its association with clinical and psychosocial determinants. The study was designed as a 3-year prospective longitudinal observational case–control study with annual assessments across three groups: men with non-dialysis CKD stages 3a/3b (eGFR <60 mL/min/1.73 m²), men with end-stage renal disease on maintenance haemodialysis, and controls without known kidney disease. In total, 267 participants were enrolled (haemodialysis n=96, CKD n=88, controls n=83). Sexual function was assessed using the IIEF-15 (total score and five subdomains), while health-related quality of life was measured with the EQ-5D-5L. The analytic strategy combined year-specific descriptive group comparisons with inferential modelling using linear mixed-effects models to estimate group differences, time trends, and the role of key covariates, including age, EQ-5D-5L, and diabetes status. Baseline profiling indicated that age was broadly comparable across groups, supporting cohort comparability for a major determinant of sexual function. In contrast, BMI differed significantly, with higher values in the CKD and control groups compared with haemodialysis. Several categorical characteristics also differed across groups, including educational level, nationality, marital and employment status, smoking patterns, and urban versus rural residence, highlighting distinct sociodemographic profiles. Importantly, the proportion reporting an active sex life was lower in haemodialysis, a clinically plausible finding reflecting the heavier overall disease burden in ESRD. Across all three years, IIEF-15 comparisons demonstrated a consistent, graded pattern: controls had the highest sexual function scores, CKD participants showed intermediate values, and haemodialysis participants exhibited the lowest scores. This stable ranking over three consecutive years supports the interpretation that sexual dysfunction in CKD, and particularly in haemodialysis, is not transient but represents a sustained condition accompanying chronic renal disease. In parallel, within-group central tendencies tended to decline over time, suggesting progressive impairment, plausibly reflecting ageing, evolving comorbidity, and cumulative chronic disease burden. Mixed-effects modelling confirmed and refined these observations. Time effects were consistently negative, with significant declines at Year 2 and further declines at Year 3 relative to Year 1 for the IIEF-15 total score and multiple subdomains. Group effects persisted after adjustment for age, EQ-5D-5L, and diabetes. Haemodialysis showed the largest deficit relative to controls for overall sexual function, while CKD also demonstrated a smaller but robust reduction. For erectile function, CKD remained significantly lower than controls, whereas haemodialysis also tended to be lower, with statistical certainty depending on the specific model and estimation uncertainty, but with a coherent pattern in adjusted trajectories. A central inferential finding was the absence of statistically significant Group×Time interactions across outcomes, indicating broadly parallel trajectories across groups over follow-up. This suggests that between-group differences were already present at the first assessment and then remained relatively stable over the 3-year period, rather than converging or diverging markedly. Clinically, this pattern is compatible with an early-established burden of sexual dysfunction in CKD and an even heavier burden in haemodialysis. Regarding determinants, EQ-5D-5L emerged as the most consistent positive correlate across models, with higher health-related quality of life strongly associated with better sexual function and higher satisfaction. Age showed a stable negative association, with small but cumulatively meaningful decreases per additional year of age. Diabetes was a prominent adverse factor. Diabetes status was consistently linked to substantially lower scores across total IIEF-15 and relevant subdomains, including erectile and orgasmic function and satisfaction-related outcomes. Type 2 diabetes displayed the largest and most stable negative effects, consistent with vascular, endothelial, and neuropathic pathways that are particularly salient in cardio-metabolic multimorbidity. The EQ-5D-5L dimension-level analyses provided clinically interpretable context. Controls more frequently reported “no problems” across dimensions such as self-care, usual activities, pain/discomfort, and anxiety/depression, whereas the clinical groups showed higher proportions at problem levels. These results do not merely indicate lower quality of life in disease groups, but also suggest that functional limitations and psychological burden co-occur with sexual dysfunction and may act as reinforcing mechanisms.In conclusion, this dissertation demonstrates that sexual function is reduced in men with CKD compared with controls, with a heavier and more pervasive burden in haemodialysis. Although a modest decline over time is detectable, the graded ranking across groups remains stable, implying that key disparities are established early and persist over three years. Health-related quality of life is a strong positive determinant, whereas age and diabetes, especially type 2 diabetes, are consistent negative factors. Clinically, the findings support routine assessment and integrated management of sexual dysfunction in CKD, prioritising interventions that improve overall functioning and quality of life and addressing cardio-metabolic risk factors such as diabetes. Key limitations include the observational nature of the study, which precludes causal inference, the possibility of residual confounding (for example, endocrine profiles, specific medications, depressive symptoms), and reliance on validated self-report instruments. Nevertheless, the longitudinal design, the three-group comparison, and the use of mixed-effects modelling that leverages repeated measurements strengthen the robustness and clinical relevance of the conclusions.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kolvatzis, Merkourios
  • Κόλβατζης, Μερκούριος

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61667

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kolvatzis, Merkourios; Κόλβατζης, Μερκούριος. Μελέτη τύπου ασθενών-μαρτύρων σε άνδρες με χρόνια νεφρική νόσο για τη διερεύνηση της φυσικής ιστορίας της στυτικής δυσλειτουργίας σε σχέση με την επίδραση της αιμοκάθαρσης σε πληθυσμό ανδρών ασθενών με χρόνια νεφρική νόσο. Aristotle University Of Thessaloniki (AUTH), 2026. http://hdl.handle.net/10442/hedi/61667